Bees, wasps, and ants, all members of the Hymenoptera order, inject a potent venom cocktail when they sting. Despite their ecological and economic significance, little was known about the origins of their venom until now. Dr. Björn von Reumont and his team at Goethe University Frankfurt conducted groundbreaking genomic studies
Bacteria and archaea, single-celled organisms, utilize CRISPR systems to defend against bacteriophages, a class of viruses. Traditionally classified into types I–VI, CRISPR systems exhibit distinct properties, including the type of enzyme used and their mechanisms for recognizing and cutting RNA or DNA. While CRISPR–Cas9 falls under type II,
Embarking on a groundbreaking journey, the Synthetic Yeast Genome project (Sc2.0) is illuminating the path toward a fully artificial eukaryotic genome. In a series of papers published in Cell and Cell Genomics, this international research consortium, led by scientists like Jef Boeke, Patrick Yizhi Cai, and Daniel Schindler, reveals
Immunotherapies: an effective Leukemia treatment option In the challenging landscape of leukemia treatment, acute and chronic myelomonocytic leukemia (AML M4/5 and CMML) present hurdles, especially for older patients. With a scant two-year survival period, standard treatments pose risks, and effective immunotherapies for CMML/AML M4/5 are lacking. However,
Introducing iBlastoids Scientists have created iBlastoids, a cutting-edge in vitro model of human blastocysts that outperforms existing systems. These mini replicas accurately mimic the structure of natural blastocysts and can generate both pluripotent and trophoblast stem cells. What’s cool about them Not only do iBlastoids effectively model early implantation